Abstract

Mounting evidence suggests that the balance of T cell costimulatory and coinhibitory signals contributes to mortality during sepsis. Here, we identified a critical role of the coinhibitory molecule T cell Ig and ITIM domain (TIGIT) in regulating sepsis mortality. Because TIGIT is significantly upregulated on memory T cells, we developed a “memory mouse” model to study the role of TIGIT during sepsis in a more physiologically relevant context. Mice received sequential pathogen exposure and developed memory T cell frequencies, similar to those observed in adult humans, and were then subjected to sepsis induction via cecal ligation and puncture. Our results show that targeting the TIGIT pathway during sepsis is fundamentally different in previously naive versus memory mice, in that αTIGIT Ab had no effect on survival in previously naive septic mice but sharply worsened survival in memory septic mice. Mechanistically, αTIGIT increased apoptosis of memory T cells, decreased T cell function, and downregulated the costimulatory receptor DNAM on memory CD8+ T cells in memory septic mice, but not in previously naive septic mice. Additionally, αTIGIT diminished Helios expression in Tregs in memory but not previously naive septic mice. These data highlight fundamental differences in the pathophysiological impact of targeting TIGIT in immunologically experienced versus previously naive hosts during sepsis.

Highlights

  • Sepsis is a life-threatening organ dysfunction that results from a dysregulated host response to infection [1]

  • Multiple studies have shown that in addition to Tregs, T cell Ig and ITIM domain (TIGIT) is primarily expressed on memory T cells and is absent on naive T cells [12, 14]

  • To determine the effect of αTIGIT Ab on bacterial clearance in the infectious site in memory versus previously naive mice with sepsis, we examined the bacterial load in peritoneal fluid (PF) at 36 hours after cecal ligation and puncture (CLP)

Read more

Summary

Introduction

Sepsis is a life-threatening organ dysfunction that results from a dysregulated host response to infection [1]. It is the most common cause of death in the intensive care unit (ICU), resulting in 20% of ICU deaths worldwide [2]. We recently demonstrated that blockade of the coinhibitory molecule 2B4 resulted in increased CLP survival in both previously healthy septic animals and in septic mice with preexisting malignancy [10, 11]. Taken together, these studies demonstrate the potential therapeutic utility of checkpoint blockade in sepsis

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call